Orca Bio
This senior scientific leadership role at Orca Bio involves designing, developing, and managing analytical methods for cell therapy products, with a specific focus on flow cytometry and method validation. The incumbent will lead a team of scientists to ensure regulatory compliance while supporting the company's clinical pipeline and manufacturing goals. Reporting to the Head of CMC, the position requires deep expertise in cell therapy analytics and a proven track record in building high-performing scientific teams.
Headquarters
Menlo Park, California, United States
Company Size
51-200 employees
Founded
2016
Orca Bio is a late-stage biotechnology company developing high-precision cell therapies for the treatment of cancer and autoimmune diseases. The company's investigational allogeneic T-cell immunotherapies harness the power of regulatory T cells with the goal of providing better patient outcomes with fewer risks. Orca Bio is committed to delivering the promise of cell therapy to patients without compromise through its high-precision technology and manufacturing approach.
Orca Bio Announces $250M in Aggregate Financing in Preparation for Potential Commercialization
Jan 9, 2026
Orca Bio’s BLA for Hematologic Malignancy Cell Therapy Orca-T Accepted by FDA With Priority Review
Oct 7, 2025
Orca Bio Presents New Clinical Data on its Pipeline of High-Precision Cell Therapies including Orca-Q® Without GvHD Prophylaxis and Orca-T/CAR-T Combination Therapy at the 67th ASH Annual Meeting
Dec 9, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Orca Bio.
Orca Bio didn’t post a salary, so this is our estimate from similar listings.
56% above the average for this role
Orca Bio, with labs in Sacramento, raises $250 million to commercialize blood cancer treatment
Jan 12, 2026
Flow Cytometry Analytical Method Development Scientist
AstraZeneca
Senior Scientist/Principle Scientist– Cell Biology and Immunology
Legend Biotech
Field Applications Manager- Flow Cytometry
Leica Biosystems
Scientist, Flow Cytometry & Cell based Assay
Altasciences
Senior Scientist, Analytical Development
Bristol Myers Squibb
Cell Potency Analytical Development Lead
Artiva Biotherapeutics